Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.

Autor: Buchroithner, Johanna1 johanna.buchroithner@kepleruniklinikum.at, Erhart, Friedrich2,3 friedrich.erhart@meduniwien.ac.at, Pichler, Josef4 Josef.Pichler@kepleruniklinikum.at, Widhalm, Georg2 georg.widhalm@meduniwien.ac.at, Preusser, Matthias5 Matthias.preusser@meduniwien.ac.at, Stockhammer, Günther6 guenther.stockhammer@i-med.ac.at, Nowosielski, Martha6 Martha.Nowosielski@i-med.ac.at, Iglseder, Sarah6 sarah.iglseder@tirol-kliniken.at, Freyschlag, Christian F.7 christian.freyschlag@i-med.ac.at, Oberndorfer, Stefan8 Stefan.Oberndorfer@stpoelten.lknoe.at, Bordihn, Karin9 k.bordihn@salk.at, von Campe, Gord10 gord.von-campe@medunigraz.at, Hoffermann, Markus10 markus.hoffermann@lkhf.at, Ruckser, Reinhard11 reinhard.ruckser@aon.at, Rössler, Karl12 Karl.roessler@uk.erlangen.de, Spiegl-Kreinecker, Sabine1 Sabine.Spiegl-Kreinecker@kepleruniklinikum.at, Fischer, Michael B.13 michael.b.fischer@meduniwien.ac.at, Czech, Thomas2 thomas.czech@meduniwien.ac.at, Visus, Carmen14 maria-carmen.visus-miguel@aoporphan.com, Krumpl, Günther14 g.krumpl@medresnet.com
Zdroj: Cancers. Oct2018, Vol. 10 Issue 10, p372. 1p.
Databáze: Academic Search Ultimate